Header cover image

South African (JSE) Pharma Industry Analysis

UpdatedMay 18, 2025
DataAggregated Company Financials
Companies4
  • 7D-1.8%
  • 3M-27.8%
  • 1Y-44.0%
  • YTDn/a

The Pharma industry has been flat over the last week, but Adcock Ingram Holdings has lost 4.2%. Unfortunately though, the industry is down 43% over the past 12 months. Earnings are forecast to grow by 20% annually.

Industry Valuation and Performance

Has the South African Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 18 May 2025R62.1bR55.9bR5.3b20.1x11.8x1.1x
Tue, 15 Apr 2025R77.6bR55.9bR5.3b21.6x14.8x1.4x
Thu, 13 Mar 2025R89.8bR56.6bR5.3b15.1x17x1.6x
Sat, 08 Feb 2025R85.2bR55.8bR5.3b14.4x16.2x1.5x
Mon, 06 Jan 2025R87.2bR55.8bR5.3b16x16.6x1.6x
Wed, 04 Dec 2024R85.4bR55.8bR5.3b14.6x16.2x1.5x
Fri, 01 Nov 2024R91.2bR55.8bR5.3b15.2x17.3x1.6x
Sun, 29 Sep 2024R97.9bR55.8bR5.3b16.2x18.6x1.8x
Tue, 27 Aug 2024R112.8bR53.8bR5.6b21x20x2.1x
Thu, 25 Jul 2024R115.2bR53.4bR5.7b21.7x20.2x2.2x
Sat, 22 Jun 2024R118.5bR53.4bR5.7b16.5x20.8x2.2x
Mon, 20 May 2024R110.8bR53.4bR5.7b15.1x19.5x2.1x
Wed, 17 Apr 2024R108.3bR53.4bR5.7b14.9x19x2x
Fri, 15 Mar 2024R101.9bR53.4bR5.5b14.2x18.7x1.9x
Sun, 11 Feb 2024R93.7bR51.4bR5.8b12.8x16x1.8x
Tue, 09 Jan 2024R99.5bR51.4bR5.8b13.7x17x1.9x
Thu, 07 Dec 2023R93.3bR51.4bR5.8b12.9x16x1.8x
Sat, 04 Nov 2023R89.2bR51.4bR5.8b12.4x15.3x1.7x
Mon, 02 Oct 2023R85.6bR51.4bR5.8b12.2x14.7x1.7x
Wed, 30 Aug 2023R91.7bR49.1bR6.4b11.9x14.2x1.9x
Fri, 28 Jul 2023R93.1bR49.0bR6.4b12.2x14.5x1.9x
Sun, 25 Jun 2023R90.1bR49.0bR6.4b11.7x14.1x1.8x
Tue, 23 May 2023R84.7bR49.0bR6.4b11.2x13.2x1.7x
Thu, 20 Apr 2023R89.0bR49.0bR6.4b11.6x13.9x1.8x
Sat, 18 Mar 2023R87.4bR49.0bR5.9b11.5x14.8x1.8x
Mon, 13 Feb 2023R74.3bR48.9bR6.5b10.3x11.4x1.5x
Wed, 11 Jan 2023R70.7bR48.9bR6.5b9.8x10.8x1.4x
Fri, 09 Dec 2022R71.6bR48.9bR6.5b9.9x11x1.5x
Sun, 06 Nov 2022R73.8bR48.9bR6.5b9.8x11.3x1.5x
Tue, 04 Oct 2022R68.2bR48.9bR6.5b9.3x10.5x1.4x
Thu, 01 Sep 2022R74.0bR48.9bR5.2b10.8x14.3x1.5x
Sat, 30 Jul 2022R73.1bR48.9bR5.2b10.9x14.2x1.5x
Mon, 27 Jun 2022R69.6bR48.9bR5.2b10.5x13.5x1.4x
Wed, 25 May 2022R78.9bR48.9bR5.2b11.5x15.3x1.6x
Price to Earnings Ratio

15.3x


Total Market Cap: R78.9bTotal Earnings: R5.2bTotal Revenue: R48.9bTotal Market Cap vs Earnings and Revenue0%0%0%
South African Pharma Industry Price to Earnings3Y Average 15.3x202320242025
Current Industry PE
  • Investors are pessimistic on the South African Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 12.0x which is lower than its 3-year average PE of 15.4x.
  • The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 4.5% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does South African Pharma compare with similar industries?

ZA Market0.85%
Healthcare-0.92%
Pharma-1.84%
Pharma-1.84%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AIP Adcock Ingram HoldingsR49.252.5%
+R174.6m
-10.5%PE9.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

APN

R122.01

Aspen Pharmacare Holdings

7D

-2.3%

1Y

-46.9%

CCC

R3.00

Cilo Cybin Holdings

7D

-24.8%

1Y

n/a

ASC

R0.81

Ascendis Health

7D

-1.2%

1Y

3.8%